Trial NCT03273153

View at ClinicalTrials.gov 
Org. Study IDs: CO39722
Secondary IDs: 2016-004387-18

Last trial update was posted on 2022-09-21

MeSH Interventions

Atezolizumab Pembrolizumab

MeSH Conditions

Melanoma

Other Conditions

Advanced BRAFV600 Wild-type Melanoma

Stopping Reasons

This study was terminated due to benefit/risk analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID